Journal of Antimicrobial Chemotherapy (1995) 36, 713-716
© 1995 The British Society for Antimicrobial Chemotherapy
brief-report |
In-vitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp
Laboratori de Micologia Institut Municipal d' Investigacio Medica Universitat Autonoma de Barcelona Avda. Dr. Aiguader 80 Barcelona, Spain
returned 12 April 1995; accepted 24 May 1995
*Correspondence to: Dr A. J. Carrillo-Munoz, Valle de Ordesa 4, 4°, 4a, 08031 Barcelona, Spain.
The in-vitro activity of sertaconazole (7-chloro-3-[l-(2,4-dichlorophenyl-l-yl)ethoxy-methyl] benzo[b]] thiophene) was compared with that of econazole and bifonazole against 150 strains of yeasts which includes six Candida species. Minimum inhibitory concentrations (MICs) were determined by a microdilution technique in Sabouraud's liquid medium, (pH 5.6). Sertaconazole (arithmetic mean MIC 0.77 mg/L) was more active than econazole (MIC 1.75 mg/L) and bifonazole (MIC 9.05 mg/L). MIC values for sertaconazole were generally and specifically lower for each tested species, Candida parapsilosis being the most susceptible (MIC 0.31 mg/L), in contrast to Candida tropicalis, which had the highest MIC (1.67 mg/L).